Congenital motor nystagmus linked to Xq26-q27

John B. Kerrison, M. Reza Vagefi, M. Michael Barmada, Irene H. Maumenee

Research output: Contribution to journalArticle

Abstract

Congenital motor nystagmus (CMN) is a hereditary disorder characterized by bilateral ocular oscillations that begin in the first 6 mo of life. It must be distinguished from those genetic disorders - such as ocular albinism (OA), congenital stationary night blindness (CSNB), and blue-cone monochromatism (BCM) - in which nystagmus accompanies a clinically apparent defect in the visual sensory system. Although CMN is presumed to arise from a neurological abnormality of fixation, it is not known whether the molecular defect is located in the eye or in the brain. It may be inherited in an autosomal dominant, autosomal recessive, or X-linked pattern. Three families with CMN inherited in an X-linked, irregularly dominant pattern were investigated with linkage and candidate gene analysis. The penetrance among obligate female carriers was 54%. Evaluation of markers in the region of the genes for X-linked OA, CSNB, and BCM revealed no evidence of linkage, supporting the hypothesis that CMN represents a distinct entity. The gene was mapped to chromosome Xq26-q27 with the following markers: GATA172D05 (LOD score 3.164; recombination fraction [θ] = 0.156), DXS1047 (LOD score 10.296; θ = O), DXS1192 (LOD score 8.174; θ = 0.027), DXS1232 (LOD score 6.015; θ = 0.036), DXS984 (LOD score 6.695; θ = 0), and GATA31E08 (LOD score 4.940; θ = 0.083). Assessment of haplotypes and multipoint linkage analysis, which gave a maximum LOD score of 10.790 with the 1-LOD-unit support interval spanning ∼7 cM, place the gene in a region between GATA172D05 and DXS1192. Evaluation of candidate genes CDR1 and SOX3 did not reveal mutations in affected male subjects.

Original languageEnglish (US)
Pages (from-to)600-607
Number of pages8
JournalAmerican Journal of Human Genetics
Volume64
Issue number2
StatePublished - 1999

Fingerprint

Ocular Albinism
Genes
X-Linked Genes
Inborn Genetic Diseases
Penetrance
Genetic Association Studies
Haplotypes
Genetic Recombination
Chromosomes
Mutation
X-Linked Infantile Nystagmus
Brain
night blue
Blue cone monochromatism
Congenital stationary night blindness

ASJC Scopus subject areas

  • Genetics

Cite this

Kerrison, J. B., Vagefi, M. R., Barmada, M. M., & Maumenee, I. H. (1999). Congenital motor nystagmus linked to Xq26-q27. American Journal of Human Genetics, 64(2), 600-607.

Congenital motor nystagmus linked to Xq26-q27. / Kerrison, John B.; Vagefi, M. Reza; Barmada, M. Michael; Maumenee, Irene H.

In: American Journal of Human Genetics, Vol. 64, No. 2, 1999, p. 600-607.

Research output: Contribution to journalArticle

Kerrison, JB, Vagefi, MR, Barmada, MM & Maumenee, IH 1999, 'Congenital motor nystagmus linked to Xq26-q27', American Journal of Human Genetics, vol. 64, no. 2, pp. 600-607.
Kerrison JB, Vagefi MR, Barmada MM, Maumenee IH. Congenital motor nystagmus linked to Xq26-q27. American Journal of Human Genetics. 1999;64(2):600-607.
Kerrison, John B. ; Vagefi, M. Reza ; Barmada, M. Michael ; Maumenee, Irene H. / Congenital motor nystagmus linked to Xq26-q27. In: American Journal of Human Genetics. 1999 ; Vol. 64, No. 2. pp. 600-607.
@article{c374e5c25e394784aeca5bf25466c79b,
title = "Congenital motor nystagmus linked to Xq26-q27",
abstract = "Congenital motor nystagmus (CMN) is a hereditary disorder characterized by bilateral ocular oscillations that begin in the first 6 mo of life. It must be distinguished from those genetic disorders - such as ocular albinism (OA), congenital stationary night blindness (CSNB), and blue-cone monochromatism (BCM) - in which nystagmus accompanies a clinically apparent defect in the visual sensory system. Although CMN is presumed to arise from a neurological abnormality of fixation, it is not known whether the molecular defect is located in the eye or in the brain. It may be inherited in an autosomal dominant, autosomal recessive, or X-linked pattern. Three families with CMN inherited in an X-linked, irregularly dominant pattern were investigated with linkage and candidate gene analysis. The penetrance among obligate female carriers was 54{\%}. Evaluation of markers in the region of the genes for X-linked OA, CSNB, and BCM revealed no evidence of linkage, supporting the hypothesis that CMN represents a distinct entity. The gene was mapped to chromosome Xq26-q27 with the following markers: GATA172D05 (LOD score 3.164; recombination fraction [θ] = 0.156), DXS1047 (LOD score 10.296; θ = O), DXS1192 (LOD score 8.174; θ = 0.027), DXS1232 (LOD score 6.015; θ = 0.036), DXS984 (LOD score 6.695; θ = 0), and GATA31E08 (LOD score 4.940; θ = 0.083). Assessment of haplotypes and multipoint linkage analysis, which gave a maximum LOD score of 10.790 with the 1-LOD-unit support interval spanning ∼7 cM, place the gene in a region between GATA172D05 and DXS1192. Evaluation of candidate genes CDR1 and SOX3 did not reveal mutations in affected male subjects.",
author = "Kerrison, {John B.} and Vagefi, {M. Reza} and Barmada, {M. Michael} and Maumenee, {Irene H.}",
year = "1999",
language = "English (US)",
volume = "64",
pages = "600--607",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - Congenital motor nystagmus linked to Xq26-q27

AU - Kerrison, John B.

AU - Vagefi, M. Reza

AU - Barmada, M. Michael

AU - Maumenee, Irene H.

PY - 1999

Y1 - 1999

N2 - Congenital motor nystagmus (CMN) is a hereditary disorder characterized by bilateral ocular oscillations that begin in the first 6 mo of life. It must be distinguished from those genetic disorders - such as ocular albinism (OA), congenital stationary night blindness (CSNB), and blue-cone monochromatism (BCM) - in which nystagmus accompanies a clinically apparent defect in the visual sensory system. Although CMN is presumed to arise from a neurological abnormality of fixation, it is not known whether the molecular defect is located in the eye or in the brain. It may be inherited in an autosomal dominant, autosomal recessive, or X-linked pattern. Three families with CMN inherited in an X-linked, irregularly dominant pattern were investigated with linkage and candidate gene analysis. The penetrance among obligate female carriers was 54%. Evaluation of markers in the region of the genes for X-linked OA, CSNB, and BCM revealed no evidence of linkage, supporting the hypothesis that CMN represents a distinct entity. The gene was mapped to chromosome Xq26-q27 with the following markers: GATA172D05 (LOD score 3.164; recombination fraction [θ] = 0.156), DXS1047 (LOD score 10.296; θ = O), DXS1192 (LOD score 8.174; θ = 0.027), DXS1232 (LOD score 6.015; θ = 0.036), DXS984 (LOD score 6.695; θ = 0), and GATA31E08 (LOD score 4.940; θ = 0.083). Assessment of haplotypes and multipoint linkage analysis, which gave a maximum LOD score of 10.790 with the 1-LOD-unit support interval spanning ∼7 cM, place the gene in a region between GATA172D05 and DXS1192. Evaluation of candidate genes CDR1 and SOX3 did not reveal mutations in affected male subjects.

AB - Congenital motor nystagmus (CMN) is a hereditary disorder characterized by bilateral ocular oscillations that begin in the first 6 mo of life. It must be distinguished from those genetic disorders - such as ocular albinism (OA), congenital stationary night blindness (CSNB), and blue-cone monochromatism (BCM) - in which nystagmus accompanies a clinically apparent defect in the visual sensory system. Although CMN is presumed to arise from a neurological abnormality of fixation, it is not known whether the molecular defect is located in the eye or in the brain. It may be inherited in an autosomal dominant, autosomal recessive, or X-linked pattern. Three families with CMN inherited in an X-linked, irregularly dominant pattern were investigated with linkage and candidate gene analysis. The penetrance among obligate female carriers was 54%. Evaluation of markers in the region of the genes for X-linked OA, CSNB, and BCM revealed no evidence of linkage, supporting the hypothesis that CMN represents a distinct entity. The gene was mapped to chromosome Xq26-q27 with the following markers: GATA172D05 (LOD score 3.164; recombination fraction [θ] = 0.156), DXS1047 (LOD score 10.296; θ = O), DXS1192 (LOD score 8.174; θ = 0.027), DXS1232 (LOD score 6.015; θ = 0.036), DXS984 (LOD score 6.695; θ = 0), and GATA31E08 (LOD score 4.940; θ = 0.083). Assessment of haplotypes and multipoint linkage analysis, which gave a maximum LOD score of 10.790 with the 1-LOD-unit support interval spanning ∼7 cM, place the gene in a region between GATA172D05 and DXS1192. Evaluation of candidate genes CDR1 and SOX3 did not reveal mutations in affected male subjects.

UR - http://www.scopus.com/inward/record.url?scp=0033070051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033070051&partnerID=8YFLogxK

M3 - Article

C2 - 9973299

AN - SCOPUS:0033070051

VL - 64

SP - 600

EP - 607

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 2

ER -